课题基金 / 基金详情

Determining the Possible Role of Hepatocyte Growth Factor Receptor Splice Site Mutation as a Key Driver in Lung Adenocarcinoma

Determining the Possible Role of Hepatocyte Growth Factor Receptor Splice Site Mutation as a Key Driver in Lung Adenocarcinoma
确定肝细胞生长因子受体剪接位点突变作为肺腺癌关键驱动因素的可能作用
批准号：
349899
负责人：
Lu Cheng-Hsiang
金额：
$1.27万
依托单位：
University of British Columbia
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-12-01 至 2016-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=349899&lang=en
关键词：
Disease Progression Driver Mutations Histology Immunohistochemistry Oncogene Addiction Signalling Pathways Survival Tetracycline-Inducible Transgenic System Tyrosine Kinase Inhibitors Tyrosine Kinase Receptors

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It is known that the DNA in cancer cells contain key changes that drive tumour development, and that cancer cells often depend on these mutations for their continued growth and survival. Therefore, identification of such changes and targeting them with in
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金